Clinical trial

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

NCT03043820

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-08-01

PhasePHASE3

Study timeline

Study start (actual)2016-08-01Date precision: month

Registry last updated2021-10-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disorderunresolved

Psychosis NOSunresolved

Interventions

RaloxifeneDRUG · verified · RxNorm: raloxifene

Sponsors & collaborators

Iris Sommerlead sponsor

Julius Centercollaborator

Rudolf Magnus Institute - University of Utrechtcollaborator

GGZ Eindhovencollaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)collaborator

GGZ Centraalcollaborator

Altrecht GGZcollaborator

Reinier van Arkel Groupcollaborator

Ziekenhuis Netwerk Antwerpen (ZNA)collaborator

Mapped research locations

UtrechtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03043820 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.